Trade this ETF at your broker
Fund size | EUR 463 m |
Total expense ratio | 0.40% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 11.27% |
Inception/ Listing Date | 8 September 2016 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | iShares |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | State Street Fund Services (Ireland) Limited |
Investment Advisor | |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Deloitte |
Fiscal Year End | 31 May |
Swiss representative | BlackRock Asset Management Schweiz AG |
Swiss paying agent | State Street Bank International GmbH, Munich, Zurich Branch |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | Bank of New York Mellon|Euroclear|JP Morgan|State Street Bank |
Securities lending | Yes |
Securities lending counterparty | Barclays Bank Plc|Barclays Capital Securities Ltd.|BNP Paribas Arbitrage SNC|BNP Paribas SA|Citigroup Global Markets Ltd|Citigroup Inc|Credit Suisse Securities (Europe) Ltd.|Deutsche Bank AG|Goldman Sachs International|HSBC Bank Plc|J.P. Morgan Securities Plc|JP Morgan Chase & Co|Macquarie Bank Limited|Merrill Lynch International|Morgan Stanley & Co. International Plc|Nomura International Plc|Skandinaviska Enskilda Banken AB|Societe Generale SA|The Bank of Nova Scotia|UBS AG |
Cytokinetics | 0.96% |
ImmunoGen | 0.87% |
Neurocrine Biosciences, Inc. | 0.70% |
Daiwa Securities Group, Inc. | 0.69% |
UBS Group AG | 0.69% |
Swedish Orphan Biovitrum AB | 0.67% |
Expedia Group, Inc. | 0.65% |
Apollo Global Management, Inc. | 0.64% |
Japan Post Holdings Co., Ltd. | 0.63% |
Karuna Therapeutics | 0.62% |
Broker | Rating | Savings plan offer | Brokerage fee | More information |
---|---|---|---|---|
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info |
YTD | +6.03% |
1 month | +1.52% |
3 months | +5.86% |
6 months | +11.52% |
1 year | +14.97% |
3 years | +4.87% |
5 years | +32.28% |
Since inception (MAX) | +50.11% |
2023 | +4.13% |
2022 | -8.47% |
2021 | +13.57% |
2020 | +3.01% |
Volatility 1 year | 11.27% |
Volatility 3 years | 14.45% |
Volatility 5 years | 18.25% |
Return per risk 1 year | 1.32 |
Return per risk 3 years | 0.11 |
Return per risk 5 years | 0.31 |
Maximum drawdown 1 year | -11.29% |
Maximum drawdown 3 years | -18.06% |
Maximum drawdown 5 years | -38.51% |
Maximum drawdown since inception | -38.51% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | 2B77 | - - | - - | - |
Stuttgart Stock Exchange | EUR | 2B77 | - - | - - | - |
Bolsa Mexicana de Valores | MXN | - | AGEDN MM | AGEDN.MX | |
Borsa Italiana | EUR | AGED | AGED IM INAVAGEE | AGED.MI | |
Euronext Amsterdam | EUR | AGED | AGED NA | ||
London Stock Exchange | GBX | AGES | AGES LN | AGES.L | |
London Stock Exchange | USD | AGED | AGED LN INAVAGEU | AGED.L 0O5ZINAV.DE | |
London Stock Exchange | GBP | - | AGES LN INAVAGEG | AGES.L 0O5XINAV.DE | |
SIX Swiss Exchange | USD | AGED | AGED SE INAVAGEU | AGED.S 0O5ZINAV.DE | |
XETRA | EUR | 2B77 | 2B77 GY INAVAGEE | 2B77.DE 0O5VINAV.DE |